The new injectable Kybella dissolves fat under the chin. (Photo: Getty Images). Before Botox, people who wanted to look younger had only one pretty drastic option—going under the knife. Today, thanks ...

NEW YORK (AP) — Botox maker Allergan Plc. is buying Kythera Biopharmaceuticals for about $2.1 billion, adding a drug that destroys fat cells and eliminates the cosmetic condition referred to as ...

The next fat profit center in the pharmaceutical industry may be the double chin. Allergan is beginning an aggressive sales blitz for Kybella, the first injectable treatment for what the medical ...

The maker of Botox is eyeing your chin. Well, chins really. Allergan is shelling out $2.1 billion for Kythera Biopharmaceuticals, which recently received a green light from the FDA for Kybella, an ...

Already hoping to erase your wrinkles, Allergan now wants to do away with double chins. The Ireland-based drug company, seller of Botox anti-wrinkle injections, agreed Wednesday to pay $2.1 billion in ...

NEW YORK (AP) — Botox maker Allergan Plc. is buying Kythera Biopharmaceuticals for about $2.1 billion, adding an injection that reduces "double chin" to its portfolio of products. The Dublin drugmaker ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...